ADMA short interest
ADMA Biologics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 20,597,867 |
|---|---|
| Change vs prior report | -3,608,882 (-14.9%) |
| Change over six months | -7.1% |
| Days to cover | 5.67 (sector: 3.78) |
| Average daily volume | 3,633,588 |
| Rank in Healthcare | #352 of 922 by days to cover |
ADMA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 20,597,867 | -14.9% | 5.67 | 3,633,588 |
| 2026-09-15 | 24,206,749 | +1.4% | 10.81 | 2,238,317 |
| 2026-08-31 | 23,870,475 | +5.2% | 13.86 | 1,721,995 |
| 2026-08-14 | 22,683,647 | +3.5% | 7.98 | 2,843,569 |
| 2026-07-31 | 21,918,195 | -8.8% | 8.83 | 2,482,967 |
| 2026-07-15 | 24,031,512 | -0.8% | 9.12 | 2,635,962 |
| 2026-06-30 | 24,232,698 | +13.9% | 5.81 | 4,167,853 |
| 2026-06-15 | 21,280,060 | +7.0% | 6.49 | 3,277,333 |
| 2026-05-29 | 19,897,126 | -0.5% | 6.03 | 3,298,981 |
| 2026-05-15 | 19,994,416 | -3.2% | 2.26 | 8,837,140 |
| 2026-04-30 | 20,658,114 | +7.0% | 3.22 | 6,419,491 |
| 2026-04-15 | 19,306,519 | -12.9% | 3.84 | 5,025,573 |
| 2026-03-31 | 22,175,506 | -14.1% | 1.64 | 13,551,247 |
| 2026-03-13 | 25,826,838 | +35.0% | 7.12 | 3,625,752 |
| 2026-02-27 | 19,137,458 | -9.1% | 5.72 | 3,345,785 |
| 2026-02-13 | 21,049,574 | +8.3% | 11.75 | 1,790,904 |
| 2026-01-30 | 19,439,065 | +4.7% | 9.19 | 2,114,860 |
| 2026-01-15 | 18,573,160 | -2.1% | 7.22 | 2,573,703 |
| 2025-12-31 | 18,972,317 | +0.8% | 9.32 | 2,036,384 |
| 2025-12-15 | 18,829,424 | +1.4% | 7.26 | 2,592,477 |
| 2025-11-28 | 18,563,031 | -0.4% | 5.87 | 3,160,341 |
| 2025-11-14 | 18,629,225 | +11.9% | 4.00 | 4,654,748 |
| 2025-10-31 | 16,649,924 | -5.2% | 5.55 | 2,999,469 |
| 2025-10-15 | 17,560,695 | +0.9% | 4.92 | 3,572,533 |
| 2025-09-30 | 17,410,928 | +10.6% | 5.14 | 3,388,600 |
import finzdata as yf
yf.Ticker("ADMA").short_interest # every report since 2017
yf.Client().short_interest(["ADMA"], start="2018-01-01")Healthcare short interest · ADMA price history · Who owns ADMA · All short interest